摘要 |
Novel mercapto-acylamino acids of the formula <CHEM> wherein Q is hydrogen or R<7>CO-; R<1> is lower alkyl, cyclolower alkyl, aryl or heteroaryl; R<2> is hydrogen; lower alkyl; cyclolower alkyl; lower alkyl substituted with hydroxy, lower alkoxy, mercapto, lower alkylthio, aryl or heteroaryl; aryl; or heteroaryl; R<3> is -OR<5>or -NR<5>N<6>; R<4> and R<9> are independently -(CH2)qR<8>, provided that when R<4> and R<9> are both hydrogen, R<2> is biphenylyl, phenoxyphenyl, phenylthiophenyl, naphthyl, heteroaryl, or lower alkyl substituted with hydroxy, lower alkoxy, mercapto or lower alkylthio; R<5> and R<6> are independently selected from the group consisting of hydrogen, lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl and aryl lower alkyl, or R<5> and R<6> together with the nitrogen to which they are attached form a 5-7 membered ring; R<7> is hydrogen, lower alkyl or aryl; R<8> is hydrogen, hydroxy, lower alkoxy, mercapto, lower alkylthio, aryl or heteroaryl; n is 1 or 2; p is 0 or 1; q is 0, 1 or 2; and t is 0 or 1; and the pharmaceutically acceptable salts thereof useful in the treatment of cardiovascular disorders and pain conditions and combinations of mercapto-acylamino acids and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating cardiovascular disorders are disclosed. |